AI is rapidly transforming the advanced therapeutics industry, offering unprecedented opportunities for innovation in areas like drug discovery, precision medicine, and clinical trials. However, integrating AI also presents significant challenges, from patent prosecution to inventorship and licensing issues. This panel will explore both the opportunities and the complexities that AI brings to advanced therapeutics.

Key discussion points will include:

• Exploring how AI can reduce timelines and costs in drug discovery, streamline clinical trials, and enhance the development of novel therapies through big data analysis, predictive modeling and enhanced targeting.
• Effective strategies for patent prosecution for AI innovations in the life sciences and advanced therapeutics space
• Navigating IP and inventorship challenges associated with patenting and licensing of AI-driven therapeutics